224 related articles for article (PubMed ID: 12377319)
1. Treatment of prostate cancer with radiotherapy: should the entire seminal vesicles be included in the clinical target volume?
Kestin L; Goldstein N; Vicini F; Yan D; Korman H; Martinez A
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):686-97. PubMed ID: 12377319
[TBL] [Abstract][Full Text] [Related]
2. Distal seminal vesicle invasion by prostate adenocarcinoma does not occur in isolation of proximal seminal vesicle invasion or lymphovascular infiltration.
Samaratunga H; Samaratunga D; Perry-Keene J; Adamson M; Yaxley J; Delahunt B
Pathology; 2010 Jun; 42(4):330-3. PubMed ID: 20438404
[TBL] [Abstract][Full Text] [Related]
3. Indications for excluding the seminal vesicles when treating clinically localized prostatic adenocarcinoma with radiotherapy alone.
Katcher J; Kupelian PA; Zippe C; Klein EA; Sohn JW
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):871-6. PubMed ID: 9128964
[TBL] [Abstract][Full Text] [Related]
4. Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland.
Merrick GS; Butler WM; Galbreath RW; Lief JH; Adamovich E
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):664-73. PubMed ID: 11849788
[TBL] [Abstract][Full Text] [Related]
5. Is seminal vesicle ablation mandatory for all patients undergoing radical prostatectomy? A multivariate analysis on 1283 patients.
Zlotta AR; Roumeguère T; Ravery V; Hoffmann P; Montorsi F; Türkeri L; Dobrovrits M; Scattoni V; Ekane S; Bollens R; Vanden Bossche M; Djavan B; Boccon-Gibod L; Schulman CC;
Eur Urol; 2004 Jul; 46(1):42-9. PubMed ID: 15183546
[TBL] [Abstract][Full Text] [Related]
6. Analysis of risk factors of involvement of seminal vesicles in patients with prostate cancer undergoing radical prostatectomy.
Dall'Oglio MF; Sant'Anna AC; Antunes AA; Nesrallah LJ; Leite KR; Srougi M
Int Braz J Urol; 2004; 30(6):472-8. PubMed ID: 15663804
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic analysis of extracapsular extension in prostate cancer: should the clinical target volume be expanded posterolaterally to account for microscopic extension?
Chao KK; Goldstein NS; Yan D; Vargas CE; Ghilezan MI; Korman HJ; Kernen KM; Hollander JB; Gonzalez JA; Martinez AA; Vicini FA; Kestin LL
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):999-1007. PubMed ID: 16750320
[TBL] [Abstract][Full Text] [Related]
8. Optimal contouring of seminal vesicle for definitive radiotherapy of localized prostate cancer: comparison between EORTC prostate cancer radiotherapy guideline, RTOG0815 protocol and actual anatomy.
Qi X; Gao XS; Asaumi J; Zhang M; Li HZ; Ma MW; Zhao B; Li FY; Wang D
Radiat Oncol; 2014 Dec; 9():288. PubMed ID: 25526901
[TBL] [Abstract][Full Text] [Related]
9. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
Kupelian PA; Katcher J; Levin HS; Klein EA
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811
[TBL] [Abstract][Full Text] [Related]
10. Optimizing patient selection for dose escalation techniques using the prostate-specific antigen level, biopsy gleason score, and clinical T-stage.
D'Amico AV; Whittington R; Malkowicz SB; Schultz D; Renshaw AA; Tomaszewski JE; Richie JP; Wein A
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1227-33. PubMed ID: 10613317
[TBL] [Abstract][Full Text] [Related]
11. Equivalent 5-year bNED in select prostate cancer patients managed with surgery or radiation therapy despite exclusion of the seminal vesicles from the CTV.
D'Amico AV; Whittington R; Kaplan I; Beard C; Schultz D; Malkowicz SB; Tomaszewski JE; Wein A; Coleman CN
Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):335-40. PubMed ID: 9308936
[TBL] [Abstract][Full Text] [Related]
12. Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database.
Freedland SJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Dorey F; Presti JC;
J Urol; 2003 Jun; 169(6):2136-41. PubMed ID: 12771735
[TBL] [Abstract][Full Text] [Related]
13. Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer.
Kupelian P; Katcher J; Levin H; Zippe C; Klein E
Urology; 1996 Aug; 48(2):249-60. PubMed ID: 8753737
[TBL] [Abstract][Full Text] [Related]
14. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
[TBL] [Abstract][Full Text] [Related]
15. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
[TBL] [Abstract][Full Text] [Related]
16. Seminal vesicle biopsy: accuracy and implications for staging of prostate cancer.
Linzer DG; Stock RG; Stone NN; Ratnow R; Ianuzzi C; Unger P
Urology; 1996 Nov; 48(5):757-61. PubMed ID: 8911521
[TBL] [Abstract][Full Text] [Related]
17. Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database.
Freedland SJ; Presti JC; Terris MK; Kane CJ; Aronson WJ; Dorey F; Amling CL;
J Urol; 2003 Jun; 169(6):2129-35. PubMed ID: 12771734
[TBL] [Abstract][Full Text] [Related]
18. Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series.
Tilki D; Schlenker B; John M; Buchner A; Stanislaus P; Gratzke C; Karl A; Tan GY; Ergün S; Tewari AK; Stief CG; Seitz M; Reich O
Urol Oncol; 2011; 29(5):508-14. PubMed ID: 19837614
[TBL] [Abstract][Full Text] [Related]
19. Improvement in relapse-free survival throughout the PSA era in patients with localized prostate cancer treated with definitive radiotherapy: year of treatment an independent predictor of outcome.
Kupelian PA; Buchsbaum JC; Elshaikh MA; Reddy CA; Klein EA
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):629-34. PubMed ID: 14529766
[TBL] [Abstract][Full Text] [Related]
20. Preoperative prostate specific antigen and prostate volume are significant predictors of seminal vesicle invasion in patients with prostate cancer.
Sfoungaristos S; Perimenis P
Prague Med Rep; 2011; 112(4):263-71. PubMed ID: 22142521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
